Hemangeol - (4.28 mg/mL; Oral Solution)

Generic Name	Propranolol Hydrochloride	Innovator	Pierre Fabre
Dosage	4.28 mg/mL; Oral Solution	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	HEMANGEOL oral solution is a beta-adrenergic blocker indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****** ******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****
******* ********	** \ **	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events